Skip navigation, view page content

OSU masthead and toolbar

The Ohio State University
www.osu.edu
  1. Help
  2. Campus map
  3. Find people
  4. Webmail

Research Unit on Pediatric Psychopharmacology    
Research Unit on Pediatric Psychopharmacology

Research Unit on Pediatric Psychopharmacology at The Nisonger Center

 

Clinical Studies for Children and Adolescents with Autism Spectrum Disorder, Pervasive Developmental Disorder (PDD), and other disorders

Our list of clinical studies provides contact information and links to basic participation requirements.
Please check this page frequently. New studies will be posted prior to subject recruiting.

Autism/PDD Studies   ||   Completed Studies   ||   Other Studies

Current Autism and PDD Studies

Cholesterol in ASD: Characterization and Treatment
Click Here for a Printable Flyer

Study of Investigational Medication and Parent Training Sessions for Treatment of Overactivity, Inattention, and Impulsivity in Children Diagnosed with Autistic Disorder
Click Here for a Printable Flyer

Study of an Investigational Possible New Treatment for Autism
Click Here for a Printable Flyer

Research in Sleep Disturbance Associated with Pervasive Developmental Disorder

Researchers at The Ohio State University's Nisonger Center are testing the effects of melatonin supplementation in children with autism spectrum disorders and sleep disturbance.
Click Here for a Printable Flyer

For more information, please contact Jill Hollway at 614-247-6402 or hollway.3@osu.edu.

Completed Autism and PDD Studies

Study of an Investigational Medication for Repetitive Behaviors in Children with Autistic Disorder

Research in Serious Behavioral Problems Associated With Autistic Disorder

Study of Risperidone (Risperdal) and Behavioral Therapy in Children with Pervasive Developmental Disorders

Study of a Medication for Gastrointestinal Problems in Autistic Children

Study of the Pharmacokinetic Parameters of Risperidone in Patients with Autism Spectrum Disorders and Tourette Syndrome
Ages 4 - 21

Risperidone on Cognitive Motor Performance and Motor Movements in Children with Disruptive Behavior Disorders

Pharmacogenetics of Risperidone in Children with PDD, Ages 4 -21 (Adults eligible)

A Study of Atomoxetine (Strattera™) for Children and Adolescents with Autism, Asperger's Syndrome, or other Pervasive Developmental Disorder (PDD) and Signs of Attention-Deficit/Hyperactivity Disorder (ADHD)

Ritalin® Treatment or Guanfacine for Hyperactivity/Impulsiveness in Children with Pervasive Developmental Disorders

Measurement of Risperidone and 9-hydroxyrisperidone in Saliva and Plasma

 

Other Studies

***Check back frequently for updates***

^Back to top